The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease

Canadian Journal of Gastroenterology

Volumn 26, Issue 3, 2012, Pages 155-159

  Al Busafi, Said A ^a,b   Ghali, Peter ^a   Wong, Philip ^a   Novales Diaz, Javier A ^c   Deschênes, Marc ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Nonalcoholic fatty liver disease; Ultrasonography; Xenon 133 liver scan

Indexed keywords

XENON 133;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER EXAMINATION; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATHOLOGIST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84858202055     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/796313     Document Type: Article

References (41)

1. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol 2002;17:1136-43. (Pubitemid 36015607)
2. Matteoni CA, Younossi ZM, Gramlich T, et al. Non-alcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9. (Pubitemid 29258890)
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
4. Nomura H, Kashiwagi S, Hayashi J, et al. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988;27:142-9.
5. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000;132:112-7. (Pubitemid 30044177)
6. Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-6. (Pubitemid 28112021)
7. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity: An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-9.
8. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children: Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-32. (Pubitemid 27339358)
9. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: A clinical histopathological study. Am J Gastroenterol 2003;98:2042-7. (Pubitemid 37185803)
10. Daniel S, Ben-Menachem T, Vasudevan G, et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999;94:3010-4. (Pubitemid 29482774)
11. Clark JM, Brancati FL, Diehl AME. Nonalcoholic fatty liver disease: The most common cause of abnormal liver enzymes in the U.S. population. Gastroenterology 2001;120(Suppl):A-65.
12. Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579-84. (Pubitemid 46672668)
13. Falck-Ytter Y, Younossi ZM, Marchesini G, et al. Clinical features and natural history of non-alcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26. (Pubitemid 32240483)
14. Sheth SG, Gordon FD, Chopra S. Non-alcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
15. Oliva MR, Mortele KJ, Segatto E, et al. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 2006;30:37-43. (Pubitemid 43052296)
16. McGill DB, Rakela J, Zinsmeister AR, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400. (Pubitemid 20381876)
17. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-906 (Pubitemid 40824701)
18. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50. (Pubitemid 34977081)
19. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001;21:71-80. (Pubitemid 32240487)
20. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007;188:1307-12. (Pubitemid 46668513)
21. Cho CS, Curran S, Schwartz LH, et al. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg 2008;206:480-8. (Pubitemid 351282515)
22. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995;5:281-5.
23. Thomsen C, Becker U, Winkler K, et al. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994;12:487-95. (Pubitemid 24113193)
24. Scott WW, Sanders AC, Siegelman SS. Irregular fatty infiltration of the liver: Diagnostic dilemmas. AJR 1980;135:67-71. (Pubitemid 10073011)
25. Mulhern CT Jr, Arger PH, Coleman BG, et al. Nonuniform attenuation in computed tomography study of the cirrhotic liver. Radiology 1979;132:399-402. (Pubitemid 9202834)
26. Kim EE, Deland FH, Maruyama Y, et al. Detection of lipoid tumors by xenon-133. J Nucl Med 1978;19:64-6. (Pubitemid 8270097)
27. Carey JE, Purdy JM, Moses DC. Localization of 133Xe in the liver during ventilation studies. J Nucl Med 1974;15:1179-81.
28. Ahmad M, Witztum KF, Fletcher JW, et al. Xenon-133 accumulation in hepatic steatosis. J Nucl Med 1977;18:881-4.
29. Bianco JA, Shafer RB. Implications of liver activity associated with 133Xe ventilation lung scans. Clin Nucl Med 1978;3:176-8. (Pubitemid 9001603)
30. Shaffer RB, Bianco JA. Implication of hepatic xenon activity in ventilation scans. J Nucl Med 1979;20:450-2. (Pubitemid 9175853)
31. Sutherland JB, McCarthy DS, Mark RJ, et al. 133Xe uptake by fatty livers. J Can Assoc Radiol 1978;29:82-4.
32. Sutherland JB, Palser AF. Quantitation of fat in liver by Xenon uptake. J Can Assoc Radiol 979;30:216-7.
33. Abroad M, Perrillo RP, Young CS, et al. Xenon-133 retention in hepatic stenosis - correlation with liver biopsy in 45 patients: Concise communication. J Nucl Med 1979;20:397-401. (Pubitemid 9185695)
34. Yeh SH, Wu LC, Wang SJ, et al. Xenon-133 hepatic retention ratio: A useful index for fatty liver quantification. J Nucl Med 1989;30:1708-12.
35. Atkins HL, Robertson JS, Croft BY, et al. Estimates of radiation absorbed doses from radioxenons in lung imaging. J Nucl Med 1980;21:459-65. (Pubitemid 10105848)
36. Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004;14:635-7. (Pubitemid 38716583)
37. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74. (Pubitemid 29420675)
38. Sanford NL, Walsh P, Matis C, et al. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology 1985;89:186-91. (Pubitemid 15057930)
39. Caturelli E, Squillante MM, Andriulli A, et al. Hypoechoic lesions in the "bright liver": A reliable indicator of fatty change. A prospective study. J Gastroenterol Hepatol 1992;7:469-72.
40. Celle G, Savarino V, Picciotto A, et al. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Sci 1988;33:467-71.
41. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292:13-5. (Pubitemid 16175875)